881 related articles for article (PubMed ID: 33014208)
1. How COVID-19 induces cytokine storm with high mortality.
Hojyo S; Uchida M; Tanaka K; Hasebe R; Tanaka Y; Murakami M; Hirano T
Inflamm Regen; 2020; 40():37. PubMed ID: 33014208
[TBL] [Abstract][Full Text] [Related]
2. The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19.
Attiq A; Yao LJ; Afzal S; Khan MA
Int Immunopharmacol; 2021 Dec; 101(Pt B):108255. PubMed ID: 34688149
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
[TBL] [Abstract][Full Text] [Related]
4. IL-6 in inflammation, autoimmunity and cancer.
Hirano T
Int Immunol; 2021 Mar; 33(3):127-148. PubMed ID: 33337480
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
Shibabaw T
J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
[TBL] [Abstract][Full Text] [Related]
6. Silibinin and SARS-CoV-2: Dual Targeting of Host Cytokine Storm and Virus Replication Machinery for Clinical Management of COVID-19 Patients.
Bosch-Barrera J; Martin-Castillo B; Buxó M; Brunet J; Encinar JA; Menendez JA
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32517353
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning.
Gantla MR; Tsigelny IF; Kouznetsova VL
Med Drug Discov; 2023 Feb; 17():100148. PubMed ID: 36466363
[TBL] [Abstract][Full Text] [Related]
8. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
Mannino F; Bitto A; Irrera N
Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
[TBL] [Abstract][Full Text] [Related]
9. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19.
Morenikeji OB; Bernard K; Strutton E; Wallace M; Thomas BN
Front Bioeng Biotechnol; 2020; 8():582953. PubMed ID: 33520952
[TBL] [Abstract][Full Text] [Related]
10. The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome.
Cesta MC; Zippoli M; Marsiglia C; Gavioli EM; Mantelli F; Allegretti M; Balk RA
Front Pharmacol; 2021; 12():808797. PubMed ID: 35095519
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
[TBL] [Abstract][Full Text] [Related]
12. Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19.
Chatterjee SK; Saha S; Munoz MNM
Front Mol Biosci; 2020; 7():196. PubMed ID: 32850977
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus 2 infection: Role of interleukin-6 and the inflammatory cascade.
Bahmani M; Chegini R; Ghanbari E; Sheykhsaran E; Shiri Aghbash P; Leylabadlo HE; Moradian E; Kazemzadeh Houjaghan AM; Bannazadeh Baghi H
World J Virol; 2022 May; 11(3):113-128. PubMed ID: 35665236
[TBL] [Abstract][Full Text] [Related]
14. When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It.
Cappanera S; Palumbo M; Kwan SH; Priante G; Martella LA; Saraca LM; Sicari F; Vernelli C; Di Giuli C; Andreani P; Mariottini A; Francucci M; Sensi E; Costantini M; Bruzzone P; D'Andrea V; Gioia S; Cirocchi R; Tiri B
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33467466
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus disease 2019 (COVID-19): cytokine storms, hyper-inflammatory phenotypes, and acute respiratory distress syndrome.
Lin SH; Zhao YS; Zhou DX; Zhou FC; Xu F
Genes Dis; 2020 Dec; 7(4):520-527. PubMed ID: 32837983
[TBL] [Abstract][Full Text] [Related]
16. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
Nagarkatti P; Miranda K; Nagarkatti M
Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
[TBL] [Abstract][Full Text] [Related]
17. Intravenous N-Acetylcysteine in Management of COVID-19: A Case Series.
Chen B; Raja K; Pierre-Louis F; Patel M; Patel R; Kang S; Daniel N; Attalla M; Philips M
J Pharm Pract; 2023 Aug; 36(4):1008-1014. PubMed ID: 35331045
[TBL] [Abstract][Full Text] [Related]
18. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm.
Kim H; Lee HS; Ahn JH; Hong KS; Jang JG; An J; Mun YH; Yoo SY; Choi YJ; Yun MY; Song GY; Joo J; Na DH; Kim HN; Park HH; Lee JY; Lee W
Nano Today; 2021 Jun; 38():101149. PubMed ID: 33846686
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the expression of proinflammatory cytokines induced by SARS-CoV-2.
Zhang XN; Wu LJ; Kong X; Zheng BY; Zhang Z; He ZW
World J Clin Cases; 2021 Mar; 9(7):1513-1523. PubMed ID: 33728295
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.
Chen R; Huang Y; Quan J; Liu J; Wang H; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Heliyon; 2020 Dec; 6(12):e05672. PubMed ID: 33313438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
